NL-OMON55114已完成不适用
DISCOvERIE: Development, dIagnosis, and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe - DISCOvERIE
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 102 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 102
研究概览
简要总结
Trial ended prematurely
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Diagnosis of IBS according to Rome IV criteria
- •- Aged 18 years or older
- •- Ability to understand written Dutch and speak the Dutch language
排除标准
- •- Any organic explanation for the abdominal complaints.
- •- A history of abdominal surgery, except for uncomplicated appendectomy,
- •laparoscopic cholecystectomy, and hysterectomy.
- •- Participation in another clinical study interfering with study activities or
- •study objectives of this study, 1 month prior to the screening visit and
- •throughout the study.
- •- Other severe disease(s) such as malignancy, severe heart disease, kidney
- •disease or neurological disease, interfering with study evaluations.
- •- Severe psychiatric disease, other than the comorbid conditions explicitly
- •studied, with necessary additional psychopharmacotherapy or psychiatric
- •intervention involving day-care/ inpatient treatment at start of study or
- •during the study, especially a diagnosis of bipolar disorder, schizophrenia,
- •autism spectrum disorder, schizoaffective disorder or organic psychiatric
- •disorder (current OR lifetime).
- •- Previous history of drug or alcohol abuse 6 months prior to screening.
- •- Consumption of antibiotics 3 months prior to the baseline visit.
- •- Pregnant or lactating at the baseline visit.
研究者
相似试验
已完成
不适用
A prospective, multicenter clinical study to evaluate the safety profile of the FlexiSurge Adhesion Barrier for the prevention of intra-abdominal adhesion formation after laparotomyvorming van adhesies na buikchirurgieadhesion formationpostoperative adhesionsNL-OMON40303Medisse BV5
已完成
不适用
A Phase 1b, Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 plus Tilsotolimod and Other Therapy Combinations in Subjects with Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaNL-OMON49382AbbVie B.V.2
已完成
不适用
A preoperative program to promote peri- and postoperative health in patients undergoing thoracic aortic surgery: a randomized controlled trial.thoracic aortic disease100122211000318410002363thoracic aortic aneurysmNL-OMON50977Radboud Universitair Medisch Centrum3
已完成
不适用
A prospective clinical follow up study with a New Press-fit Cup with initial RSA analysis (NPC).worn hip10023213OsteoarthritisNL-OMON46964Stichting SCORE28
已完成
2 期
A Phase 1-2, Open-Label, Dose-Finding, Proof of Concept, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CX-2009 in Adults with Metastatic or Locally Advanced Unresectable Solid TumorsNL-OMON48575CytomX Therapeutics, Inc.22